Protective action of luminal bile salts in necrotizing acute pancreatitis in mice.
Open Access
- 1 July 1990
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 86 (1) , 323-331
- https://doi.org/10.1172/jci114703
Abstract
Bile salts in the intestinal lumen act to inhibit the release of cholecystokinin (CCK). Recent studies have shown that CCK may play a permissive role in the development of acute pancreatitis. In this study, the amount of luminal bile salts in female Swiss Webster mice was either decreased by feeding 4% (wt/wt) cholestyramine or increased by feeding 0.5% sodium taurocholate for 1 wk. Plasma levels of CCK were stimulated by cholestyramine and inhibited by taurocholate. Then, acute pancreatitis was induced either by caerulein injections, or by feeding a choline-deficient, ethionine-supplemented (CDE) diet. Feeding of cholestyramine significantly decreased survival from 25% to 0% in the CDE pancreatitis, and increased the magnitude of elevation of serum amylase levels and the extent of pancreatic necrosis in both models of pancreatitis; CCK-receptor blockade with CR-1409 completely abolished the adverse effects of cholestyramine. In contrast, feeding of taurocholate significantly increased survival to 100% and decreased the elevation of serum amylase and pancreatic necrosis; CCK-8 antagonized these actions of taurocholate. Luminal bile salts appear to provide a physiologic protection against necrotizing pancreatitis, at least in part, both by inhibiting the release of CCK and by promoting resistance of the pancreas to CCK excessive stimulation in vivo.This publication has 28 references indexed in Scilit:
- Failure of a Potent Cholecystokinin Antagonist to Protect Against Diet-Induced Pancreatitis in MicePancreas, 1989
- Effect of cholestyramine on plasma cholecystokinin and pancreatic polypeptide levels, and exocrine pancreatic secretionEuropean Journal of Clinical Investigation, 1988
- Asperlicin, A Nonpeptidal Cholecystokinin Receptor Antagonist, Attenuates Sodium Taurocholate-Induced Acute Pancreatitis in RatsPancreas, 1988
- Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis.Journal of Clinical Investigation, 1986
- Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the ratBritish Journal of Surgery, 1985
- Plasma secretin in response to pure bile salts and endogenous bile in manDigestive Diseases and Sciences, 1985
- Protective effects of exogenous secretin on ceruletide-induced acute pancreatitis in the rat.Journal of Clinical Investigation, 1983
- Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity.Journal of Clinical Investigation, 1977
- Mechanisms of Lithogenic Bile Formation in American Indian Women with Cholesterol GallstonesJournal of Clinical Investigation, 1972
- Quantification of the Binding Tendencies of Cholestyramine I: Effect of Structure and Added Electrolytes on the Binding of Unconjugated and Conjugated Bile-Salt AnionsJournal of Pharmaceutical Sciences, 1969